Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Magnesium bisglycinate is a **chelated form of magnesium** where each magnesium ion is bound to two molecules of the amino acid glycine, enhancing its stability and gastrointestinal absorption[2][3][5]. This chelation markedly improves magnesium’s bioavailability and reduces the risk of diarrhea compared to other magnesium salt forms such as oxide or citrate[1][4]. Magnesium is a cofactor in over 300 enzymatic reactions critical for energy production, muscle contraction, nerve signal transmission, blood pressure regulation, bone health, and more[1][2][4][5]. The glycine component also provides calming effects and further supports nervous system function[1][2]. Magnesium bisglycinate is primarily used to correct or prevent magnesium deficiency, support muscle function, improve sleep and stress resilience, aid cardiovascular and bone health, and relieve symptoms such as muscle cramps, migraines, or PMS[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on magnesium bisglycinate.